Akkaraju Srinivas's most recent trade in Mineralys Therapeutics Inc was a trade of 8,300 Stock Option done . Disclosure was reported to the exchange on Feb. 19, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Mineralys Therapeutics Inc | Srinivas Akkaraju | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2026 | 8,300 | 8,300 | - | - | Stock Option | |
| Mineralys Therapeutics Inc | Srinivas Akkaraju | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2026 | 6,200 | 6,200 | - | 0 | Common Stock | |
| Alumis Inc | Srinivas Akkaraju | Director | Purchase of securities on an exchange or from another person at price $ 17.00 per share. | 09 Jan 2026 | 588,235 | 1,853,488 | - | 17 | 9,999,995 | Common Stock |
| Kalaris Therapeutics Inc | Srinivas Akkaraju | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 10.00 per share. | 22 Dec 2025 | 1,500,000 | 1,500,000 | - | 10 | 15,000,000 | Common Stock |
| Kalaris Therapeutics Inc | Srinivas Akkaraju | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 10.42 per share. | 18 Dec 2025 | 479,847 | 1,979,847 | - | 10.4 | 5,000,006 | Common Stock |
| Alumis Inc | Srinivas Akkaraju | Director | Purchase of securities on an exchange or from another person at price $ 10.01 per share. | 05 Dec 2025 | 70,028 | 1,213,873 | - | 10.0 | 700,980 | Common Stock |
| Alumis Inc | Srinivas Akkaraju | Director | Purchase of securities on an exchange or from another person at price $ 8.95 per share. | 05 Dec 2025 | 64,969 | 1,143,845 | - | 9.0 | 581,473 | Common Stock |
| Alumis Inc | Srinivas Akkaraju | Director | Purchase of securities on an exchange or from another person at price $ 10.73 per share. | 05 Dec 2025 | 51,380 | 1,265,253 | - | 10.7 | 551,307 | Common Stock |
| Alumis Inc | Srinivas Akkaraju | Director | Purchase of securities on an exchange or from another person at price $ 7.75 per share. | 02 Dec 2025 | 100,000 | 1,012,849 | - | 7.8 | 775,000 | Common Stock |
| Alumis Inc | Srinivas Akkaraju | Director | Purchase of securities on an exchange or from another person at price $ 7.55 per share. | 02 Dec 2025 | 96,000 | 912,849 | - | 7.6 | 724,800 | Common Stock |
| Alumis Inc | Srinivas Akkaraju | Director | Purchase of securities on an exchange or from another person at price $ 8.18 per share. | 02 Dec 2025 | 66,027 | 1,078,876 | - | 8.2 | 540,101 | Common Stock |
| Alumis Inc | Srinivas Akkaraju | Director | Purchase of securities on an exchange or from another person at price $ 7.46 per share. | 26 Nov 2025 | 86,350 | 816,849 | - | 7.5 | 644,171 | Common Stock |
| Alumis Inc | Srinivas Akkaraju | Director | Purchase of securities on an exchange or from another person at price $ 7.64 per share. | 26 Nov 2025 | 48,537 | 691,797 | - | 7.6 | 370,823 | Common Stock |
| Alumis Inc | Srinivas Akkaraju | Director | Purchase of securities on an exchange or from another person at price $ 7.64 per share. | 26 Nov 2025 | 38,702 | 730,499 | - | 7.6 | 295,683 | Common Stock |
| Alumis Inc | Srinivas Akkaraju | Director | Purchase of securities on an exchange or from another person at price $ 7.20 per share. | 20 Nov 2025 | 125,743 | 643,260 | - | 7.2 | 905,350 | Common Stock |
| Alumis Inc | Srinivas Akkaraju | Director | Purchase of securities on an exchange or from another person at price $ 6.56 per share. | 17 Nov 2025 | 137,772 | 517,517 | - | 6.6 | 903,784 | Common Stock |
| Alumis Inc | Srinivas Akkaraju | Director | Purchase of securities on an exchange or from another person at price $ 6.05 per share. | 17 Nov 2025 | 102,652 | 379,745 | - | 6.1 | 621,045 | Common Stock |
| Alumis Inc | Srinivas Akkaraju | Director | Purchase of securities on an exchange or from another person at price $ 5.51 per share. | 17 Nov 2025 | 914 | 277,093 | - | 5.5 | 5,036 | Common Stock |
| Alumis Inc | Srinivas Akkaraju | Director | Purchase of securities on an exchange or from another person at price $ 5.25 per share. | 13 Nov 2025 | 276,179 | 276,179 | - | 5.3 | 1,449,940 | Common Stock |
| Scholar Rock Holding Corp | Srinivas Akkaraju | Director | 07 Oct 2025 | 1,064,804 | 6,367,614 (21%) | 3% | 7.3 | 7,826,309 | Common Stock | |
| Scholar Rock Holding Corp | Srinivas Akkaraju | Director | 07 Oct 2025 | 1,064,804 | 0 | - | - | Warrants to Purchase Common Stock | ||
| Scholar Rock Holding Corp | Srinivas Akkaraju | Director | Purchase of securities on an exchange or from another person at price $ 39.31 per share. | 07 Oct 2025 | 12,796 | 513,235 (1%) | 0% | 39.3 | 503,011 | Common Stock |
| Scholar Rock Holding Corp | Srinivas Akkaraju | Director | Purchase of securities on an exchange or from another person at price $ 40.18 per share. | 07 Oct 2025 | 12,400 | 525,635 (1%) | 0% | 40.2 | 498,232 | Common Stock |
| Scholar Rock Holding Corp | Srinivas Akkaraju | Director | Purchase of securities on an exchange or from another person at price $ 40.97 per share. | 07 Oct 2025 | 4,403 | 530,038 (1%) | 0% | 41.0 | 180,391 | Common Stock |
| Scholar Rock Holding Corp | Srinivas Akkaraju | Director | Purchase of securities on an exchange or from another person at price $ 37.42 per share. | 03 Oct 2025 | 319,700 | 387,414 (1%) | 1% | 37.4 | 11,963,174 | Common Stock |
| Scholar Rock Holding Corp | Srinivas Akkaraju | Director | Purchase of securities on an exchange or from another person at price $ 38.68 per share. | 03 Oct 2025 | 80,863 | 486,691 (1%) | 0% | 38.7 | 3,127,781 | Common Stock |
| Scholar Rock Holding Corp | Srinivas Akkaraju | Director | Purchase of securities on an exchange or from another person at price $ 36.74 per share. | 03 Oct 2025 | 56,703 | 67,714 (0%) | 0% | 36.7 | 2,083,268 | Common Stock |
| Scholar Rock Holding Corp | Srinivas Akkaraju | Director | Purchase of securities on an exchange or from another person at price $ 37.89 per share. | 03 Oct 2025 | 18,414 | 405,828 (1%) | 0% | 37.9 | 697,706 | Common Stock |
| Scholar Rock Holding Corp | Srinivas Akkaraju | Director | Purchase of securities on an exchange or from another person at price $ 39.52 per share. | 03 Oct 2025 | 13,748 | 500,439 (1%) | 0% | 39.5 | 543,321 | Common Stock |
| Scholar Rock Holding Corp | Srinivas Akkaraju | Director | Purchase of securities on an exchange or from another person at price $ 35.61 per share. | 03 Oct 2025 | 11,011 | 11,011 (0%) | 0% | 35.6 | 392,102 | Common Stock |
| Mineralys Therapeutics Inc | Srinivas Akkaraju | Director | Purchase of securities on an exchange or from another person at price $ 25.50 per share. | 04 Sep 2025 | 588,235 | 588,235 | - | 25.5 | 14,999,993 | Common Stock |
| Alumis Inc | Srinivas Akkaraju | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2025 | 49,800 | 49,800 | - | - | Stock Option (Right to Buy) | |
| Scholar Rock Holding Corp | Srinivas Akkaraju | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2025 | 9,206 | 9,206 | - | - | Stock Option (Right to Buy) | |
| Scholar Rock Holding Corp | Srinivas Akkaraju | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2025 | 7,632 | 21,132 (0%) | 0% | 0 | Common Stock | |
| Alumis Inc | Srinivas Akkaraju | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2025 | 1,214,582 | 4,801,370 | - | - | Common Stock | |
| Alumis Inc | Srinivas Akkaraju | Director | Purchase of securities on an exchange or from another person at price $ 4.55 per share. | 02 May 2025 | 159,920 | 3,426,418 | - | 4.6 | 727,636 | Common Stock |
| Alumis Inc | Srinivas Akkaraju | Director | Purchase of securities on an exchange or from another person at price $ 4.58 per share. | 02 May 2025 | 138,368 | 3,564,786 | - | 4.6 | 633,725 | Common Stock |
| Alumis Inc | Srinivas Akkaraju | Director | Purchase of securities on an exchange or from another person at price $ 5.27 per share. | 02 May 2025 | 22,002 | 3,586,788 | - | 5.3 | 115,951 | Common Stock |
| Kalaris Therapeutics Inc | Srinivas Akkaraju | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2025 | 18,000 | 18,000 | - | - | Stock Option (Right to Buy) | |
| Mineralys Therapeutics Inc | Srinivas Akkaraju | Director | Purchase of securities on an exchange or from another person at price $ 13.50 per share. | 13 Mar 2025 | 600,000 | 5,674,916 | - | 13.5 | 8,100,000 | Common Stock |
| Mineralys Therapeutics Inc | Srinivas Akkaraju | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 32,900 | 32,900 | - | - | Stock Option | |
| Scholar Rock Holding Corp | Srinivas Akkaraju | Director | Sale of securities on an exchange or to another person at price $ 27.50 per share. | 07 Oct 2024 | 510,000 | 6,278,609 (21%) | 1% | 27.5 | 14,025,000 | Common Stock |
| Scholar Rock Holding Corp | Srinivas Akkaraju | Director | Sale of securities on an exchange or to another person at price $ 30.00 per share. | 07 Oct 2024 | 510,000 | 5,768,609 (19%) | 1% | 30 | 15,300,000 | Common Stock |
| Scholar Rock Holding Corp | Srinivas Akkaraju | Director | Sale of securities on an exchange or to another person at price $ 32.50 per share. | 07 Oct 2024 | 155,713 | 5,612,896 (18%) | 0% | 32.5 | 5,060,673 | Common Stock |
| Syros Pharmaceuticals Inc | Srinivas Akkaraju | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Sep 2024 | 2,667 | 2,667 | - | - | Restricted Stock Units | |
| Syros Pharmaceuticals Inc | Srinivas Akkaraju | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Sep 2024 | 2,667 | 9,333 (0%) | 0% | - | Common Stock | |
| Alumis Inc | Srinivas Akkaraju | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2024 | 1,703,998 | 0 | - | - | Class A Common Stock | |
| Alumis Inc | Srinivas Akkaraju | Director | 01 Jul 2024 | 1,703,998 | 1,703,998 | - | - | Class A Common Stock | ||
| Alumis Inc | Srinivas Akkaraju | Director | 01 Jul 2024 | 1,703,998 | 0 | - | - | Series C Preferred Stock | ||
| Alumis Inc | Srinivas Akkaraju | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 1,703,998 | 1,703,998 | - | - | Common Stock | |
| Alumis Inc | Srinivas Akkaraju | Director | Purchase of securities on an exchange or from another person at price $ 16.00 per share. | 01 Jul 2024 | 1,562,500 | 3,266,498 | - | 16 | 25,000,000 | Common Stock |
| Scholar Rock Holding Corp | Srinivas Akkaraju | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2024 | 18,000 | 18,000 | - | - | Stock Option (Right to Buy) | |
| Scholar Rock Holding Corp | Srinivas Akkaraju | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2024 | 13,500 | 13,500 (0%) | 0% | 0 | Common Stock | |
| Syros Pharmaceuticals Inc | Srinivas Akkaraju | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 6,000 | 6,000 | - | - | Stock Option (right to buy) | |
| Syros Pharmaceuticals Inc | Srinivas Akkaraju | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 4,000 | 4,000 | - | - | Restricted Stock Units | |
| Syros Pharmaceuticals Inc | Srinivas Akkaraju | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2024 | 4,000 | 0 | - | - | Restricted Stock Units | |
| Syros Pharmaceuticals Inc | Srinivas Akkaraju | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2024 | 4,000 | 6,666 (0%) | 0% | - | Common Stock | |
| Mineralys Therapeutics Inc | Srinivas Akkaraju | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 22,000 | 22,000 | - | - | Stock Option | |
| Mineralys Therapeutics Inc | Akkaraju Srinivas | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 13.50 per share. | 12 Feb 2024 | 555,555 | 5,074,916 | - | 13.5 | 7,499,993 | Common Stock |
| Syros Pharmaceuticals Inc | Srinivas Akkaraju | Director | Purchase of securities on an exchange or from another person at price $ 4.42 per share. | 21 Dec 2023 | 904,977 | 1,786,427 (4%) | 2% | 4.4 | 3,999,998 | Common Stock |
| Scholar Rock Holding Corp | Srinivas Akkaraju | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2023 | 36,000 | 36,000 | - | - | Stock Option (Right to Buy) | |
| Syros Pharmaceuticals Inc | Srinivas Akkaraju | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 6,000 | 6,000 | - | - | Stock Option (right to buy) | |
| Syros Pharmaceuticals Inc | Srinivas Akkaraju | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 4,000 | 4,000 | - | - | Restricted Stock Units | |
| Intercept Pharmaceuticals Inc | Srinivas Akkaraju | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2023 | 12,547 | 12,547 | - | - | Option to Purchase Common Stock | |
| Intercept Pharmaceuticals Inc | Srinivas Akkaraju | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2023 | 8,111 | 45,998 (0%) | 0% | 0 | Common Stock | |
| Mineralys Therapeutics Inc | Srinivas Akkaraju | Director, Ten Percent Owner | 14 Feb 2023 | 3,581,861 | 3,581,861 | - | - | Common Stock | ||
| Mineralys Therapeutics Inc | Srinivas Akkaraju | Director, Ten Percent Owner | 14 Feb 2023 | 2,135,504 | 0 | - | - | Series A Preferred Stock | ||
| Mineralys Therapeutics Inc | Srinivas Akkaraju | Director, Ten Percent Owner | 14 Feb 2023 | 1,446,357 | 0 | - | - | Series B Preferred Stock | ||
| Mineralys Therapeutics Inc | Srinivas Akkaraju | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 16.00 per share. | 14 Feb 2023 | 937,500 | 4,519,361 | - | 16 | 15,000,000 | Common Stock |
| Mineralys Therapeutics Inc | Srinivas Akkaraju | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 44,000 | 44,000 | - | - | Stock Option | |
| Syros Pharmaceuticals Inc | Srinivas Akkaraju | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Sep 2022 | 691,489 | 691,489 | - | - | Warrants (right to buy) | |
| Syros Pharmaceuticals Inc | Srinivas Akkaraju | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Sep 2022 | 691,489 | 881,450 (2%) | 1% | - | Common Stock | |
| Scholar Rock Holding Corp | Srinivas Akkaraju | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Sep 2022 | 56,000 | 56,000 | - | - | Stock Option (Right to Buy) | |
| Syros Pharmaceuticals Inc | Srinivas Akkaraju | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Sep 2022 | 12,000 | 12,000 | - | - | Stock Option (right to buy) | |
| Syros Pharmaceuticals Inc | Srinivas Akkaraju | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Sep 2022 | 8,000 | 8,000 | - | - | Restricted Stock Units | |
| Syros Pharmaceuticals Inc | Srinivas Akkaraju | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 17,500 | 17,500 | - | - | Stock Option (right to buy) | |
| Intercept Pharmaceuticals Inc | Srinivas Akkaraju | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2022 | 12,790 | 12,790 | - | - | Option to Purchase Common Stock | |
| Intercept Pharmaceuticals Inc | Srinivas Akkaraju | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2022 | 7,737 | 37,887 (0%) | 0% | 0 | Common Stock | |
| Syros Pharmaceuticals Inc | Srinivas Akkaraju | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2021 | 17,500 | 17,500 | - | - | Stock Option (right to buy) | |
| Intercept Pharmaceuticals Inc | Srinivas Akkaraju | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2021 | 12,089 | 12,089 | - | - | Option to Purchase Common Stock | |
| Intercept Pharmaceuticals Inc | Srinivas Akkaraju | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2021 | 7,029 | 30,150 (0%) | 0% | 0 | Common Stock | |
| Intercept Pharmaceuticals Inc | Srinivas Akkaraju | Director | Purchase of securities on an exchange or from another person at price $ 21.29 per share. | 10 Mar 2021 | 147,000 | 640,688 (1%) | 0% | 21.3 | 3,129,630 | Common Stock |
| Intercept Pharmaceuticals Inc | Srinivas Akkaraju | Director | Purchase of securities on an exchange or from another person at price $ 20.83 per share. | 10 Mar 2021 | 73,441 | 477,129 (1%) | 0% | 20.8 | 1,529,776 | Common Stock |
| Intercept Pharmaceuticals Inc | Srinivas Akkaraju | Director | Purchase of securities on an exchange or from another person at price $ 21.55 per share. | 10 Mar 2021 | 16,559 | 493,688 (1%) | 0% | 21.5 | 356,846 | Common Stock |